Joe Barton said...
It looks to me like we have two issues here. We have an FDA issue, you are right, seeing Ms. Woodcock.
Context
Barton identifies FDA and CMS issues regarding drug approval and pricing.
02/03/2016
Barton identifies FDA and CMS issues regarding drug approval and pricing.